Site- and structure-specific quantitative N-glycoproteomics study of differential N-glycosylation in MCF-7 cancer cells
- PMID: 31759178
- DOI: 10.1016/j.jprot.2019.103594
Site- and structure-specific quantitative N-glycoproteomics study of differential N-glycosylation in MCF-7 cancer cells
Abstract
Glycosylation is a common protein PTM, and its aberrant regulation has been widely linked to various pathological conditions including cancers. Our recent development of intact N-glycopeptide search engine GPSeeker has enabled relatively quantitative structure-specific characterization of differentially expressed intact N-glycopeptides (DEGPs) with isotopic labeling of the peptide backbones and structure-specific fragment ions of the N-glycan moieties. Here we report our site- and structure-specific relatively quantitative N-glycoproteomics study of breast MCF-7 cancer cells (relative to epithelial MCF-10A cells) using RPLC-nanoESI-MS/MS and GPSeeker. With spectrum-level FDR ≤ 1%, 581 intact N-glycopeptides with comprehensive structural information of both the peptide backbones (amino acid sequences, N-glycosites) and the N-glycan moieties (monosaccharide composition, sequence and linkages) were identified from five technical replicates (TR1, TR2, TR3, TR4 and TR5). With the criteria of quantified at least thrice out of the five technical replicates with no <1.5-fold change, p ≤ .05 and RSD ≤ 20%, 56 DEGPs were quantified from 23 N-glycosites on 19 intact N-glycoproteins. For the 19 intact N-glycoproteins observed with differential N-glycosylation expression, 14 (each with one or more DEGPs) were observed with uniform down regulation; 6 (each with one or more DEGPs) were observed with uniform up regulation; whereas one was observed with both up and down regulation. SIGNIFICANCE: Differential N-glycosylation in breast MCF-7 cancer cells (relative to MCF-10A epithelial cells) were qualitatively and quantitatively characterized with site- and structure-specific N-glycoproteomics using RPLC-nanoESI-MS/MS (HCD with stepped NCEs) and intact N-glycopeptide search engine GPSeeker. With spectrum-level FDR ≤ 1%, 581 intact N-glycopeptides with comprehensive structural information of both the peptide backbones and the N-glycan moieties were identified; For the 248 putative N-glycosites, 248 were confirmed where 125 have not been annotated in UniProt as of July 25, 2019. For the 114 N-glycan putative linkage structures, 44 were confirmed with no less than one structure-diagnostic fragment ions. With the criteria of quantified at least thrice out of the five technical replicates with no < 1.5-fold change and p ≤ .05, 56 DEGPs were quantified from 21 intact N-glycoproteins; 13 and 5 intact N-glycoproteins (each with one or more DEGPs) were observed with uniform down and up regulation; whereas one were observed with simultaneous up and down regulation.
Keywords: Differential N-glycosylation; GPSeeker; Isotopic diethyl labeling; MCF-7; Relatively quantitative structural N-glycoproteomics.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Mass spectrometry-based structure-specific N-glycoproteomics and biomedical applications.Acta Biochim Biophys Sin (Shanghai). 2024 Aug 8;56(8):1172-1183. doi: 10.3724/abbs.2024133. Acta Biochim Biophys Sin (Shanghai). 2024. PMID: 39118567 Free PMC article. Review.
-
Putative N-glycoprotein markers of MCF-7/ADR cancer stem cells from N-glycoproteomics characterization of the whole cell lysate.Talanta. 2021 Sep 1;232:122437. doi: 10.1016/j.talanta.2021.122437. Epub 2021 Apr 30. Talanta. 2021. PMID: 34074422
-
GPSeeker Enables Quantitative Structural N-Glycoproteomics for Site- and Structure-Specific Characterization of Differentially Expressed N-Glycosylation in Hepatocellular Carcinoma.J Proteome Res. 2019 Jul 5;18(7):2885-2895. doi: 10.1021/acs.jproteome.9b00191. Epub 2019 Jun 3. J Proteome Res. 2019. PMID: 31117584
-
A quantitative N-glycoproteomics study of cell-surface N-glycoprotein markers of MCF-7/ADR cancer stem cells.Anal Bioanal Chem. 2020 Apr;412(11):2423-2432. doi: 10.1007/s00216-020-02453-7. Epub 2020 Feb 7. Anal Bioanal Chem. 2020. PMID: 32030495
-
[Recent advances in glycopeptide enrichment and mass spectrometry data interpretation approaches for glycoproteomics analyses].Se Pu. 2021 Oct;39(10):1045-1054. doi: 10.3724/SP.J.1123.2021.06011. Se Pu. 2021. PMID: 34505426 Free PMC article. Review. Chinese.
Cited by
-
Recent Advances in Analytical Approaches for Glycan and Glycopeptide Quantitation.Mol Cell Proteomics. 2021;20:100054. doi: 10.1074/mcp.R120.002095. Epub 2021 Feb 20. Mol Cell Proteomics. 2021. PMID: 32576592 Free PMC article. Review.
-
N-Glycoproteomics Study of Putative N-Glycoprotein Biomarkers of Drug Resistance in MCF-7/ADR Cells.Phenomics. 2021 Oct 28;1(6):269-284. doi: 10.1007/s43657-021-00029-8. eCollection 2021 Dec. Phenomics. 2021. PMID: 36939756 Free PMC article.
-
Mass spectrometry-based structure-specific N-glycoproteomics and biomedical applications.Acta Biochim Biophys Sin (Shanghai). 2024 Aug 8;56(8):1172-1183. doi: 10.3724/abbs.2024133. Acta Biochim Biophys Sin (Shanghai). 2024. PMID: 39118567 Free PMC article. Review.
-
Data-Independent Acquisition-Based Mass Spectrometry (DIA-MS) for Quantitative Analysis of Intact N-Linked Glycopeptides.Anal Chem. 2021 Oct 19;93(41):13774-13782. doi: 10.1021/acs.analchem.1c01659. Epub 2021 Oct 8. Anal Chem. 2021. PMID: 34622651 Free PMC article.
-
The glycosylation in SARS-CoV-2 and its receptor ACE2.Signal Transduct Target Ther. 2021 Nov 15;6(1):396. doi: 10.1038/s41392-021-00809-8. Signal Transduct Target Ther. 2021. PMID: 34782609 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials